Clinical Trial Update: Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 window-of-opportunity trial evaluating topical tranexamic acid for cutaneous squamous cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Topical tranexamic acid (tranexamic acid)

Snippet

Sponsor: University of Florida | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: WITHDRAWN